{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"thrombocytopenia-6","columns":[{"gene":"","key":"population-c02404733573c962361c","label":"Thrombocytopenia 6","mondoId":"MONDO:0014837","onsetQualifier":null,"originColumnKey":"MONDO:0014837/OMIM:616937","originalViews":[{"key":"MONDO:0014837/OMIM:616937","label":"Thrombocytopenia 6","scopeLabel":"OMIM:616937","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0d2b0d96d6c18c128273fcdced2ae8778a3ddb437ce1e5b6d082f88a935fd38f","216634cc0aaedbafed2e324f88b46ae266d80f1141980b0934bcadd92a919552","2193087916504b7d2d2f7ff9d8e058d81abf81ef4c49abc30dc1a9f69d3a3ea7","4e371059fed9006709bd6f5829329bf349da380e5d6f29bca37bd1fa8b4bce93","7eeffb640b20200807648e19809c02d54f11a9b2e653e295d589dc7f8af3cd0a","7fd760f9c1e72fd24138bec52a3989b9356bc7b345795a05e43ba8179cddbcf5","9242551f8e25d88989bfbe05748428c0f09a90059c49f82269f524f33c358caf","f03bd99957034bc0f36167ec3b5f5f69b94d7a8dac671f5b9879164716b90df6","fb8b46a9ae39771479daa440cbb2ea13d9679e035709e754e262191e961ea36f"],"recordQualifiers":{},"scopeLabel":"OMIM:616937","sourceIds":["OMIM:616937"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-c02404733573c962361c"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001892","HP:0031020","HP:0000490","HP:0000601","HP:0002003","HP:0011974","HP:0000939"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":9,"sourceGroups":{"omim":1,"published":8}},"features":[{"hpoId":"HP:0001892","label":"Abnormal bleeding","primary":true},{"hpoId":"HP:0031020","label":"Bone marrow hypercellularity","primary":true},{"hpoId":"HP:0000490","label":"Deeply set eye","primary":true},{"hpoId":"HP:0000601","label":"Hypotelorism","primary":true},{"hpoId":"HP:0002003","label":"Large forehead","primary":true},{"hpoId":"HP:0011974","label":"Myelofibrosis","primary":true},{"hpoId":"HP:0000939","label":"Osteoporosis","primary":true},{"hpoId":"HP:0004406","label":"Spontaneous, recurrent epistaxis","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false}],"ledeHtml":"A rare syndromic constitutional thrombocytopenia characterized by thrombocytopenia with increased bleeding tendency (leading to epistaxis, menorrhagia, and petechiae), in combination with myelofibrosis and splenomegaly. Platelets may be abnormally large or small and partly hypo- or agranular, plasma thrombopoietin is elevated, and the number of megakaryocytes in the bone marrow increased. Additional non-hematologic manifestations have been described in some patients, including mild bone abnormalities and facial dysmorphism with large forehead, hypertelorism, deep-set eyes, and wide nostrils.","mondoId":"MONDO:0014837","node":{"canonicalSlug":"thrombocytopenia-6","comparisons":[{"documentSha256":"225e59a492db4647c447b8da1a29e7eaa7095e7bf5e8735a1b053d914216f23f","key":"legacy-thrombocytopenia-6","kind":"legacy","label":"thrombocytopenia 6","memberIds":["MONDO:0014837"],"mondoId":"MONDO:0014837","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/thrombocytopenia-6.225e59a492db4647c447b8da1a29e7eaa7095e7bf5e8735a1b053d914216f23f.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Thrombocytopenia 6","originalSourceId":"ORPHA:480851","paragraphs":["A rare syndromic constitutional thrombocytopenia characterized by thrombocytopenia with increased bleeding tendency (leading to epistaxis, menorrhagia, and petechiae), in combination with myelofibrosis and splenomegaly. Platelets may be abnormally large or small and partly hypo- or agranular, plasma thrombopoietin is elevated, and the number of megakaryocytes in the bone marrow increased. Additional non-hematologic manifestations have been described in some patients, including mild bone abnormalities and facial dysmorphism with large forehead, hypertelorism, deep-set eyes, and wide nostrils."],"rawAttribution":"ORPHA:480851","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:03:01Z","upstream":"ORPHA:480851","url":"https://rarediseases.info.nih.gov/diseases/17870"},"ownColumnKeys":["population-c02404733573c962361c"],"publication":"published","relationships":[{"kind":"parent","label":"syndromic constitutional thrombocytopenia","mondoId":"MONDO:0018795","slug":null},{"kind":"parent","label":"myeloproliferative neoplasm","mondoId":"MONDO:0020076","slug":"myeloproliferative-neoplasm"},{"kind":"parent","label":"hereditary disorder of connective tissue","mondoId":"MONDO:0023603","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"0d2b0d96d6c18c128273fcdced2ae8778a3ddb437ce1e5b6d082f88a935fd38f","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:616937","disease_name":"Thrombocytopenia 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000601","is_excluded":false,"label":"Hypotelorism","onset_id":null,"reference":"PMID:26936507","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"216634cc0aaedbafed2e324f88b46ae266d80f1141980b0934bcadd92a919552","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:616937","disease_name":"Thrombocytopenia 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002003","is_excluded":false,"label":"Large forehead","onset_id":null,"reference":"PMID:26936507","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2193087916504b7d2d2f7ff9d8e058d81abf81ef4c49abc30dc1a9f69d3a3ea7","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616937","disease_name":"Thrombocytopenia 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004406","is_excluded":false,"label":"Spontaneous, recurrent epistaxis","onset_id":null,"reference":"PMID:26936507","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"4e371059fed9006709bd6f5829329bf349da380e5d6f29bca37bd1fa8b4bce93","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616937","disease_name":"Thrombocytopenia 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"PMID:26936507","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7eeffb640b20200807648e19809c02d54f11a9b2e653e295d589dc7f8af3cd0a","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616937","disease_name":"Thrombocytopenia 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0031020","is_excluded":false,"label":"Bone marrow hypercellularity","onset_id":null,"reference":"PMID:26936507","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7fd760f9c1e72fd24138bec52a3989b9356bc7b345795a05e43ba8179cddbcf5","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:616937","disease_name":"Thrombocytopenia 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000490","is_excluded":false,"label":"Deeply set eye","onset_id":null,"reference":"PMID:26936507","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"9242551f8e25d88989bfbe05748428c0f09a90059c49f82269f524f33c358caf","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616937","disease_name":"Thrombocytopenia 6","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000939","is_excluded":false,"label":"Osteoporosis","onset_id":null,"reference":"OMIM:616937","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f03bd99957034bc0f36167ec3b5f5f69b94d7a8dac671f5b9879164716b90df6","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616937","disease_name":"Thrombocytopenia 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0011974","is_excluded":false,"label":"Myelofibrosis","onset_id":null,"reference":"PMID:26936507","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"fb8b46a9ae39771479daa440cbb2ea13d9679e035709e754e262191e961ea36f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616937","disease_name":"Thrombocytopenia 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001892","is_excluded":false,"label":"Abnormal bleeding","onset_id":null,"reference":"PMID:26936507","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17870\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014837\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:480851</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare syndromic constitutional thrombocytopenia characterized by thrombocytopenia with increased bleeding tendency (leading to epistaxis, menorrhagia, and petechiae), in combination with myelofibrosis and splenomegaly. Platelets may be abnormally large or small and partly hypo- or agranular, plasma thrombopoietin is elevated, and the number of megakaryocytes in the bone marrow increased. Additional non-hematologic manifestations have been described in some patients, including mild bone abnormalities and facial dysmorphism with large forehead, hypertelorism, deep-set eyes, and wide nostrils.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17870\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"thrombocytopenia-6","sourceDocuments":[{"name":"GARD: Thrombocytopenia 6","reviewed":null,"source_release":"2026-10-21T17:03:01Z","url":"https://rarediseases.info.nih.gov/diseases/17870"},{"name":"MONDO: thrombocytopenia 6","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014837"}],"sourceNote":"","synonyms":["hereditary thrombocytopenia with early-onset myelofibrosis","SRC-related thrombocytopenia","THC6","thrombocytopenia 6"],"takeawayHtml":"","title":"thrombocytopenia 6"},"schemaVersion":1}
